EBOS Group Financials
| EBOSY Stock | USD 35.03 0.00 0.00% |
EBOS |
Understanding current and past EBOS Group Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of EBOS Group's financial statements are interrelated, with each one affecting the others. For example, an increase in EBOS Group's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in EBOS Group's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of EBOS Group Limited. Check EBOS Group's Beneish M Score to see the likelihood of EBOS Group's management manipulating its earnings.
EBOS Group Stock Summary
EBOS Group competes with Stratec SE, Fagron NV, Medacta Group, Ping An, and Zur Rose. EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia and New Zealand. EBOS Group Limited was founded in 1922 and is headquartered in Docklands, Australia. Ebos Group is traded on BATS Exchange in USA.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| Business Address | 737 Bourke Street, |
| Sector | Healthcare |
| Industry | Medical Distribution |
| Benchmark | Dow Jones Industrial |
| Website | www.ebosgroup.com |
| Phone | 61 3 9918 5555 |
| Currency | USD - US Dollar |
EBOS Group Key Financial Ratios
EBOS Group's financial ratios allow both analysts and investors to convert raw data from EBOS Group's financial statements into concise, actionable information that can be used to evaluate the performance of EBOS Group over time and compare it to other companies across industries.| Return On Equity | 0.11 | |||
| Return On Asset | 0.0449 | |||
| Beta | 0.36 | |||
| Z Score | 2.2 | |||
| Last Dividend Paid | 0.87 |
EBOS Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining EBOS Group's current stock value. Our valuation model uses many indicators to compare EBOS Group value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across EBOS Group competition to find correlations between indicators driving EBOS Group's intrinsic value. More Info.EBOS Group Limited is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers reporting about 0.40 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for EBOS Group Limited is roughly 2.49 . Comparative valuation analysis is a catch-all model that can be used if you cannot value EBOS Group by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for EBOS Group's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.EBOS Group Limited Systematic Risk
EBOS Group's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. EBOS Group volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was sixty with a total number of output elements of one. The Beta measures systematic risk based on how returns on EBOS Group Limited correlated with the market. If Beta is less than 0 EBOS Group generally moves in the opposite direction as compared to the market. If EBOS Group Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one EBOS Group Limited is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of EBOS Group is generally in the same direction as the market. If Beta > 1 EBOS Group moves generally in the same direction as, but more than the movement of the benchmark.
EBOS Group December 25, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of EBOS Group help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of EBOS Group Limited. We use our internally-developed statistical techniques to arrive at the intrinsic value of EBOS Group Limited based on widely used predictive technical indicators. In general, we focus on analyzing EBOS Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build EBOS Group's daily price indicators and compare them against related drivers.
| Information Ratio | (0.22) | |||
| Maximum Drawdown | 10.63 |
Additional Tools for EBOS Pink Sheet Analysis
When running EBOS Group's price analysis, check to measure EBOS Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EBOS Group is operating at the current time. Most of EBOS Group's value examination focuses on studying past and present price action to predict the probability of EBOS Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EBOS Group's price. Additionally, you may evaluate how the addition of EBOS Group to your portfolios can decrease your overall portfolio volatility.